290 related articles for article (PubMed ID: 7687742)
1. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
[TBL] [Abstract][Full Text] [Related]
2. Possible v-Crk-induced transformation through activation of Src kinases.
Sabe H; Shoelson SE; Hanafusa H
J Biol Chem; 1995 Dec; 270(52):31219-24. PubMed ID: 8537387
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
4. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.
Hempstead BL; Birge RB; Fajardo JE; Glassman R; Mahadeo D; Kraemer R; Hanafusa H
Mol Cell Biol; 1994 Mar; 14(3):1964-71. PubMed ID: 7509449
[TBL] [Abstract][Full Text] [Related]
5. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.
Mayer BJ; Hanafusa H
J Virol; 1990 Aug; 64(8):3581-9. PubMed ID: 1695251
[TBL] [Abstract][Full Text] [Related]
7. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
Fajardo JE; Birge RB; Hanafusa H
Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
[TBL] [Abstract][Full Text] [Related]
8. Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region.
Turner CE; Miller JT
J Cell Sci; 1994 Jun; 107 ( Pt 6)():1583-91. PubMed ID: 7525621
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor stimulates the tyrosine phosphorylation of endogenous Crk-II and augments its association with p130Cas in PC-12 cells.
Ribon V; Saltiel AR
J Biol Chem; 1996 Mar; 271(13):7375-80. PubMed ID: 8631760
[TBL] [Abstract][Full Text] [Related]
10. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk.
Schaller MD; Parsons JT
Mol Cell Biol; 1995 May; 15(5):2635-45. PubMed ID: 7537852
[TBL] [Abstract][Full Text] [Related]
11. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
[TBL] [Abstract][Full Text] [Related]
12. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.
Mayer BJ; Hanafusa H
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2638-42. PubMed ID: 1690891
[TBL] [Abstract][Full Text] [Related]
13. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
Grgurevich S; Mikhael A; McVicar DW
Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
[TBL] [Abstract][Full Text] [Related]
14. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
Matsuda M; Mayer BJ; Hanafusa H
Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
[TBL] [Abstract][Full Text] [Related]
15. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
[TBL] [Abstract][Full Text] [Related]
16. Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells.
Weng Z; Taylor JA; Turner CE; Brugge JS; Seidel-Dugan C
J Biol Chem; 1993 Jul; 268(20):14956-63. PubMed ID: 8325872
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
Salgia R; Li JL; Lo SH; Brunkhorst B; Kansas GS; Sobhany ES; Sun Y; Pisick E; Hallek M; Ernst T
J Biol Chem; 1995 Mar; 270(10):5039-47. PubMed ID: 7534286
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
[TBL] [Abstract][Full Text] [Related]
19. v-Crk-induced cell transformation: changes in focal adhesion composition and signaling.
Nievers MG; Birge RB; Greulich H; Verkleij AJ; Hanafusa H; van Bergen en Henegouwen PM
J Cell Sci; 1997 Feb; 110 ( Pt 3)():389-99. PubMed ID: 9057091
[TBL] [Abstract][Full Text] [Related]
20. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
Reichman CT; Mayer BJ; Keshav S; Hanafusa H
Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
